PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas

Author： Nakamura Jean   Karlsson Amelia   Arvold Nils   Gottschalk Alexander   Pieper Russell   Stokoe David   Haas-Kogan Daphne  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.71, Iss.3, 2005-02, pp. : 215-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3kinase/Akt/fatty acid synthase signaling pathway in vitro

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1352-1357

Spandidos Publications

Access to resources Recommend Favorite

The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation

By Imai Yasuo   Yoshimori Mayumi   Fukuda Kazunori   Yamagishi Hidetsugu   Ueda Yoshihiko  

Oncology Reports, Vol. 27, Iss. 6, 2012-06 ,pp. : 1703-1709

Spandidos Publications

Access to resources Recommend Favorite

LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 2967-2972

Spandidos Publications

Access to resources Recommend Favorite

PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus

By              

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1581-1588

Spandidos Publications

Access to resources Recommend Favorite

LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 575-579

Spandidos Publications

Access to resources Recommend Favorite